Group A (n = 172) | Group B (n = 73) | Statistical significance | Total (n = 245) | |
---|---|---|---|---|
Normal uterine cavity | 16 (9.3%) | 3 (4.1%) | p > 0.05* a | 7.8% |
Benign isolated polyp | 108 (62.8%) | 43 (58.9%) | p > 0.05* b | 61.65% |
Other benign lesions | ||||
Fibroid | 12 (7%) | 2 (2.75%) | p > 0.05* a | 5.7% |
Intrauterine adhesion | 9 (5.2%) | 3 (4.1%) | p > 0.05* a | 4.9% |
Uterine septum | 6 (3.4%) | 2 (2.75%) | p > 0.05* a | 3.3% |
Endometrial carcinoma | 5 (2.9%) | 13 (17.8%) | p = 0.03** a | 7.3% |
Endometrial hyperplasia | 2 (1.2%) | 1 (1.4%) | p > 0.05* a | 1.2% |
Multiple benign findings | ||||
Benign polyp + other | 12 (7%) | 5 (6.8%) | p > 0.05* a | 6.95% |
Other | 2 (1.2%) | 1 (1.4%) | p > 0.05* a | 1.2% |